Appetite suppressants withdrawn

October 1997
CMAJ: Canadian Medical Association Journal;10/15/97, Vol. 157 Issue 8, p1007
Academic Journal
States that Health Canada has warned consumers not to use appetite suppressants containing fenfluamine or dexfenfluramine.


Related Articles

  • Pills don't come with a seal of approval. Shute, Nancy // U.S. News & World Report;09/29/97, Vol. 123 Issue 12, p74 

    Discusses the US Food and Drug Administration's (FDA) recall in September 1997 of the prescription drugs Redux and Pondimin. The reason for the recall being development of heart-valve abnormalities; The off label uses of medications by doctors; The history of Redux through its FDA approval and...

  • Rx: Take as directed. Monroe, Judy // Current Health 2;Sep98, Vol. 25 Issue 1, p19 

    Focuses on the benefits of following directions, when taking prescription medicines. What can occur when medications are taken incorrectly; Information on drug interactions; Problems associated with prescription medicines. INSETS: Good news you can use;Getting the Info.

  • Are you getting the most from these eight common and valuable remedies?  // Modern Medicine;Mar95, Vol. 63 Issue 3, p57 

    Presents an abstract of the article `Eight Underused Prescriptions,' by C.P. Kerr dated November 15, 1995.

  • Closing drug formularies no easy, overnight job. Muirhead, Greg // Drug Topics;2/5/96, Vol. 140 Issue 3, p59 

    Focuses on formulary enforcement. Background information; Task taken on by managed care organizations (MCO); Changing attitudes of drug manufacturers; Implications; Expectations.

  • Mail-order woes for some retirees.  // Drug Topics;2/19/96, Vol. 140 Issue 4, p7 

    Focuses on the problems of retired federal workers in getting their medications filled under a Blue Cross/Blue Shield mail-order plan.

  • Drugs Most Frequently Prescribed in Physicians' Offices, 1997.  // World Almanac & Book of Facts;2000, p901 

    No abstract available.

  • A look at formularies: Prescription for success? Jones, John D. // Best's Review / Life-Health Insurance Edition;Jun96, Vol. 97 Issue 2, p78 

    Focuses on the advantages and disadvantages of drug formularies in the United States. Limited population sample; Lack of clear definitions; Definition of the goals of formularies.

  • FDA news and product notes.  // Formulary;Aug96, Vol. 31 Issue 8, p636 

    Reports on new drug approvals, dosage forms and other product announcements, as of August 1996. New molecular entities; New indications; Formulations.

  • Combining a clinical trial with decision analysis to evaluate antiemetic agents. Becker, Amy J.; Mutnick, Alan H. // Formulary;Aug96, Vol. 31 Issue 8, p670 

    Presents a study designed to determine the most cost-effective antiemetic using approved dosages for patients receiving highly emetogenic or very highly emetogenic chemotherapy. Receptor antagonists; Methods; Clinical results; Decision analysis; Identification of decision alternatives.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics